Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NASDAQ:ZYME
Watchlist
Price: 11.43 USD 0.7% Market Closed
Market Cap: 795.3m USD

Intrinsic Value

ZYME's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ZYME stock under the Base Case scenario is 13.64 USD. Compared to the current market price of 11.43 USD, Zymeworks Inc is Undervalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ZYME Intrinsic Value
13.64 USD
Undervaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Zymeworks Inc

Valuation History Unavailable

Historical valuation for ZYME cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Zymeworks Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zymeworks Inc

Current Assets 306m
Receivables 25m
Other Current Assets 281m
Non-Current Assets 120m
Long-Term Investments 56m
PP&E 33m
Intangibles 15.4m
Other Non-Current Assets 15.6m
Efficiency

Free Cash Flow Analysis
Zymeworks Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Zymeworks Inc

Revenue
93.3m USD
Operating Expenses
-218.3m USD
Operating Income
-125m USD
Other Expenses
10m USD
Net Income
-115m USD
Fundamental Scores

ZYME Profitability Score
Profitability Due Diligence

Zymeworks Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
ROE is Increasing
ROIC is Increasing
32/100
Profitability
Score

Zymeworks Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

ZYME Solvency Score
Solvency Due Diligence

Zymeworks Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
69/100
Solvency
Score

Zymeworks Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZYME Price Targets Summary
Zymeworks Inc

Wall Street analysts forecast ZYME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZYME is 22.84 USD with a low forecast of 13.13 USD and a high forecast of 31.5 USD.

Lowest
Price Target
13.13 USD
15% Upside
Average
Price Target
22.84 USD
100% Upside
Highest
Price Target
31.5 USD
176% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Zymeworks Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ZYME is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ZYME Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ZYME stock?

The intrinsic value of one ZYME stock under the Base Case scenario is 13.64 USD.

Is ZYME stock undervalued or overvalued?

Compared to the current market price of 11.43 USD, Zymeworks Inc is Undervalued by 16%.

Back to Top